| Balance Sheet of Alembic Pharmaceuticals (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
37.70 |
37.70 |
37.70 |
37.70 |
37.70 |
|
| Total Share Capital |
37.70 |
37.70 |
37.70 |
37.70 |
37.70 |
|
| Reserves and Surplus |
3,308.32 |
2,674.71 |
2,156.93 |
1,829.62 |
1,492.58 |
|
| Total Reserves and Surplus |
3,308.32 |
2,674.71 |
2,156.93 |
1,829.62 |
1,492.58 |
|
| Total Shareholders Funds |
3,346.02 |
2,712.41 |
2,194.63 |
1,867.32 |
1,530.28 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
886.99 |
499.30 |
500.00 |
0.00 |
0.00 |
|
| Deferred Tax Liabilities [Net] |
45.76 |
45.27 |
44.64 |
43.78 |
50.02 |
|
| Other Long Term Liabilities |
73.30 |
0.00 |
0.00 |
12.57 |
13.05 |
|
| Long Term Provisions |
73.21 |
51.33 |
61.33 |
57.22 |
28.23 |
|
| Total Non-Current Liabilities |
1,079.26 |
595.90 |
605.97 |
113.57 |
91.30 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
800.04 |
359.98 |
121.53 |
0.00 |
0.00 |
|
| Trade Payables |
393.17 |
529.91 |
601.98 |
465.82 |
500.21 |
|
| Other Current Liabilities |
222.11 |
318.46 |
140.28 |
48.77 |
51.32 |
|
| Short Term Provisions |
38.17 |
32.37 |
13.50 |
12.30 |
16.00 |
|
| Total Current Liabilities |
1,453.49 |
1,240.72 |
877.29 |
526.89 |
567.53 |
|
| Total Capital And Liabilities |
5,878.77 |
4,549.03 |
3,677.89 |
2,507.78 |
2,189.11 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
1,268.11 |
1,077.08 |
918.30 |
799.01 |
697.25 |
|
| Intangible Assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Capital Work-In-Progress |
1,569.98 |
1,106.89 |
740.64 |
347.75 |
92.34 |
|
| Other Assets |
8.35 |
8.35 |
0.00 |
0.00 |
0.00 |
|
| Fixed Assets |
2,846.44 |
2,192.32 |
1,658.94 |
1,146.76 |
789.59 |
|
| Non-Current Investments |
833.25 |
506.39 |
298.89 |
103.04 |
37.46 |
|
| Deferred Tax Assets [Net] |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Long Term Loans And Advances |
0.00 |
0.00 |
0.00 |
36.52 |
48.75 |
|
| Other Non-Current Assets |
47.71 |
14.31 |
44.37 |
0.00 |
0.00 |
|
| Total Non-Current Assets |
3,727.40 |
2,713.02 |
2,002.20 |
1,286.32 |
875.80 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Inventories |
1,073.19 |
891.41 |
669.93 |
574.62 |
533.72 |
|
| Trade Receivables |
784.11 |
539.75 |
621.66 |
466.06 |
371.50 |
|
| Cash And Cash Equivalents |
37.13 |
150.80 |
15.63 |
0.69 |
284.81 |
|
| Short Term Loans And Advances |
0.00 |
0.00 |
0.00 |
20.19 |
123.28 |
|
| OtherCurrentAssets |
256.94 |
254.05 |
368.47 |
159.90 |
0.00 |
|
| Total Current Assets |
2,151.37 |
1,836.01 |
1,675.69 |
1,221.46 |
1,313.31 |
|
| Total Assets |
5,878.77 |
4,549.03 |
3,677.89 |
2,507.78 |
2,189.11 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
455.59 |
409.05 |
317.89 |
394.77 |
0.00 |
|
| CIF VALUE OF IMPORTS |
|
|
|
|
|
|
| Raw Materials |
0.00 |
0.00 |
0.00 |
0.00 |
328.30 |
|
| Stores, Spares And Loose Tools |
0.00 |
0.00 |
0.00 |
0.00 |
4.81 |
|
| Trade/Other Goods |
0.00 |
0.00 |
0.00 |
0.00 |
4.81 |
|
| Capital Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| EXPENDITURE IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| Expenditure In Foreign Currency |
606.20 |
606.48 |
0.00 |
0.00 |
196.35 |
|
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS |
|
|
|
|
|
|
| Dividend Remittance In Foreign Currency |
-- |
-- |
-- |
-- |
-- |
|
| EARNINGS IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| FOB Value Of Goods |
-- |
-- |
-- |
-- |
1,755.08 |
|
| Other Earnings |
2,180.77 |
1,945.27 |
-- |
-- |
25.97 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
-- |
-- |
-- |
-- |
-- |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Non-Current Investments Unquoted Book Value |
833.25 |
506.39 |
298.89 |
103.04 |
37.46 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Current Investments Unquoted Book Value |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
